Oncology
Cancer of the Stomach
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Cancer of the Stomach is an early-stage landscape with 0 programs across 1 company. The most active players are Radiation Therapy Oncology Group.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Completed3 · 75%
Unknown status1 · 25%
Clinical Trials
Trial Activity
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Unknown status·—·Phase 2·NCT00005607
Chemotherapy for Patients With Cancer of the Stomach
Completed·—·Phase 1·NCT01928524·34 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)